Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C.
Anand
Anil C
AC
Seth
Avnish K
AK
Nagpal
Akhil
A
Varma
Prem P
PP
Gadela
S R
SR
Baliga
K V
KV
Dutta
Vibha
V
Chopra
G S
GS
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019695:Glycyrrhizic Acid / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000998:Antiviral Agents; D012254:Ribavirin; D019695:Glycyrrhizic Acid